Featured Industry Insights
Biosciences in 2022: Bioscience Reaps Benefits From the Cloud
Technological innovations brought in as a result of COVID-19 could produce dramatic changes to how we do science. In this insight, Synthace co-founder Markus Gershater previews a cloud-first future for bioscience.
Raising the Bar in Proteomics
How do we continue to push the boundaries in analytical capabilities, increase confidence in results and apply MS to a wider range of research questions? Technology Networks posed these questions to Rohan Thakur, executive vice president of Life Sciences Mass Spectrometry at Bruker Daltonics, in a recent interview.
Latest Industry Insights
An Interview With Life Chemicals
To learn more about Life Chemicals and the services it provides, Technology Networks spoke with Olga Balabon. In this interview, Olga also highlights how the company supports researchers when searching for appropriate product candidates.
Innovations and Key Themes for ASMS 2021
While many of us are still attending events remotely, ASMS 2021 has been in full swing this year with in-person talks and events. To give you a taste of the topics proving popular this year, Technology Networks has produced a round up to highlight a selection of key themes and innovations.
Building a Stronger Clinical Trials Industry Post-Pandemic: Modal-Guided Design
The focus on COVID-19 has caused many trials to be delayed, canceled or scaled back – meaning that the development of new medicines for patients in other areas has been slowed. At the same time, it has exposed pre-existing flaws in the industry. To recover from the pandemic, the industry must now address these underlying issues.
Agilent Science Futures – An Interview With Alexandra Richardson
In this interview, Alexandra Richardson tells us more about her research, the role that technology is playing in it and how important industry partnerships have been.
Overcoming Challenges of Biologic Characterization
To learn more about the Biophase 8800 system and how it can help to overcome current bioanalytical challenges, Technology Networks spoke to Mani Krishnan, vice president and general manager, SCIEX CE and Biopharma.
Thinking Differently: The Potential of Psilocybin Therapy To Transform the Mental Healthcare Landscape
Poor mental health is a growing burden on global healthcare systems. In this opinion piece, Compass Pathways chief medical officer Professor Guy Goodwin reviews currently available treatments options and the results from his company's new clinical trial into the efficacy of the psychedelic psilocybin in treating mental health conditions.
Using Artificial Intelligence To Detect Melanoma
To find out more about how AI can improve melanoma diagnosis, Technology Networks spoke to Dr. Kiran Motaparthi, director of dermatopathology and clinical associate professor of dermatology at the University of Florida and Julianna Ianni, PhD, vice president of AI R&D, Proscia.
Driving Innovation in Insect Farming
What benefits can insect protein offer? How are regulatory frameworks impacting innovation in this field? And what can be done to drive further advances? Technology Networks had the pleasure of speaking with Thomas Farrugia, chief executive officer of Beta Bugs Limited, to answer these questions and more.
Developing a Vaccine for Alzheimer’s Disease
To learn more about a universal vaccine technology and how the platform could be applied to Alzheimer's disease and other neurological indications, Technology Networks spoke with Roman Kniazev, chief executive officer at Nuravax.
Agilent Science Futures – The Impact of Academia–Industry Relationships on the Next Generation of Scientists
There is an inherent link between academia and industry that rarely gets the acknowledgement it deserves. Hear from a roundtable of PhD students on the impact that the collaborative relationship between academia and industry has on their work and the role that technology plays in the “Science Futures” initiative.